Author + information
- Published online July 15, 2020.
- Kiran Mahmood, MDa,∗,
- Eman R. Rashed, MD, PhDa,∗,
- Estefania Oliveros, MDa,
- Vinh Q. Chau, MDa,
- Taylor Hermle, PA-Cb,
- Samantha Jacobs, MDc,
- Anuradha Lala, MDa,
- Aditi Singhvi, MDa,
- Aditya Parikh, MDa and
- Sean P. Pinney, MDa,∗ ()
- aZena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York
- bDepartment of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York
- cDepartment of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York
- ↵∗Address for correspondence:
Dr. Sean P. Pinney, Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, New York 10029.
There is a desperate search to discover effective therapies against coronavirus disease-2019 (COVID-19). Patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) comprise a unique population whose clinical course may provide insights into the effects of antiretroviral therapy on COVID-19. We describe the case of a patient with HIV/AIDS on left ventricular assist device support who was hospitalized and recovered from COVID-19. (Level of Difficulty: Intermediate.)
↵∗ Drs. Mahmood and Rashed contributed equally to this work.
Dr. Pinney has received consulting fees from Abbott, CareDx, Medtronic, and Procyrion. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- 2020 The Authors